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Abstract
Regulation of viral transcription by chromatin structure has emerged as a fundamental determinant in the establishment of
lytic and latent herpesvirus infections. The Polycomb group (PcG) of epigenetic repressors promotes heterochromatin
formation by trimethylating histone H3 on lysine-27 (H3K27me3) and regulates development, stem cell renewal and
differentiation and the cell cycle. These cellular processes are tightly coupled to the molecular switch between lytic and
latent herpesvirus infections. Using chromatin immunoprecipitation analysis, we observed enrichment of H3K27me3 at the
major immediate-early (MIE) locus of murine cytomegalovirus (MCMV) very early following infection of permissive
fibroblasts. As lytic replication progressed, we observed a loss of H3K27me3 enrichment concomitant with the appearance
of H3K4me3. However, late during infection, as viral replication centers are established, we observed a significant increase in
PcG protein association with chromatin. Additionally, in co-immunofluorescence assays using confocal microscopy, we
detected strong enrichments for PcG protein within the viral replication compartment, suggesting an association between
viral DNA synthesis machinery and PcG proteins. Together, our results suggest a novel, dynamic interaction between PcG
epigenetic repressors and MCMV genomes.
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Introduction
Human cytomegalovirus (HCMV) is a b-herpesvirus and a
ubiquitous human pathogen [1]. HCMV infections are frequently
associated with opportunistic disease in immunocompromised
hosts, such as AIDS patients, cancer patients and bone marrow
and solid organ transplant recipients. Transplacental transmission
of HCMV from mother to fetus is also a major concern, as it can
result in serious sequelae, ranging from sensorineural hearing loss
and developmental deficits to death. Like all herpesviruses,
HCMV persists for the lifetime of the host, maintaining a latent
infection in hematopoietic progenitor cells of the myeloid lineage
[2]. Reactivation of latent virus to acute replication promotes
transmission, causes opportunistic disease in immunocompromised
hosts, and likely promotes reseeding of the latent reservoir.
The lytic and latent phases of HCMV replication depend upon
a highly regulated program of viral gene expression that relies on
the coordinated interaction of viral and cellular factors. During
HCMV replication in permissive cells, viral genes are expressed in
a temporal cascade. Immediate early (IE) genes are expressed from
the genome first, independent of any other gene expression.
Expression of viral Early (E) and Late (L) genes subsequently
follows and depends upon robust IE gene expression. Protein
products of the HCMV Major Immediate Early Promoter (MIEP),
namely IE1-72 and IE2-86, play a central role in driving the acute
replication cycle, as well as promoting reactivation from latency
[3]. As there is no animal model for HCMV infection, murine
cytomegalovirus (MCMV) is widely used as a model system to
study the regulation of b-herpesvirus gene expression both in vitro
and in vivo. Studies of cytomegalovirus infections suggest that
control of MIEP activity and, consequently, expression levels of IE
proteins, is a critical determinant of whether the lytic or latent
transcriptional program is executed [4,5]. Both HCMV and
MCMV MIE enhancer/promoter regions are complex, transcrip-
tional regulatory modules, rich in cis-acting regulatory elements.
These sequences are recognized by both positive and negative
cellular transcriptional regulators (i.e. YY1, CREB/ATF and NF-
kB), whose functions are regulated by both virus and host factors.
Tertiary chromatin structure also contributes to MIE enhancer/
promoter regulation, where heterochromatin specifies transcrip-
tional quiescence during latency, and euchromatin permits
transcriptional activation of the region during acute infections
and reactivation. Identifying the factors that control this molecular
switch between chromatin states is crucial to understanding the
mechanisms governing acute and latent infections.
DNA-templated processes in eukaryotic cells, such as transcrip-
tion, replication and repair, are universally influenced by
chromatin structure. The basic building block of all chromatin is
the nucleosome and the amino-terminal tails of all four core
histones are subject to a myriad of post-translational modifications
(PTMs) [6]. This ‘‘histone code’’ allows for the generation of
distinct epigenetic micro-environments by altering nucleosome
properties and chromatin compaction states, and by recruiting
trans-acting factors to establish or maintain various chromatin
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transcriptionally active euchromatin (EC) and highly-condensed,
transcriptionally silent heterochromatin (HC) [8]. HC is further
subdivided into constitutive or facultative heterochromatin (cHC
or fHC). cHC is found at highly condensed genomic regions such
as centromeres, telomeres and highly repetitive transposable
elements, and lacks the potential to revert to transcriptionally
active EC [9]. On the other hand, fHC, though transcriptionally
silent, retains the potential to convert to transcriptionally active
EC. Reversibly silenced fHC domains span genes often required
for cell cycle regulation or developmental processes, such as the
INK4a locus and the HOX genes [10,11]. While the establish-
ment and maintenance of fHC depends on a number of cellular
processes, post-translational modifications of histones are of
primary importance in the recognition and function of fHC.
fHC is characterized by enrichment of histone H3 trimethylated
on lysine 27 (H3K27me3) and to a lesser extent, with histone H3
di- and trimethylated on lysine 9 (H3K9me2/3). H3K27
trimethylation is catalyzed by the multi-protein effector complex,
Polycomb Repressive Complex 2 (PRC2). EZH2 is the catalytic
subunit of PRC2 and must bind to two other PRC2 subunits,
SUZ12 and EED, for full activity. Additionally, while not required
for PRC2 histone methyltransferase activity, the histone binding
proteins RbAp46/48, and PHF1 are also PRC2 accessory
subunits. In the establishment and maintenance of fHC, PRC2
cooperates with a second, functionally related complex known as
PRC1 that modifies histone H2A on lysine 119 (H2AK119ub).
This dual marking of nucleosomes is proposed to target chromatin
for compaction and the exclusion of RNA polymerase, both
critical to the maintenance of reversibly silenced chromatin [12].
The activities of the cellular Trithorax group proteins functionally
oppose transcriptional repression by PRC1 and PRC2 and
facilitate transcriptional activation [13]. Specifically, a Trithorax
group protein known as KDM6A/B demethylates H3K27me3
while MLL1-3 catalyzes trimethylation of histone H3 on lysine-4
(H3K4me3), promoting transcriptional activation and elongation.
As a result, cellular gene expression is dynamically regulated by
the interplay of Polycomb group (PcG) and Trithorax group
(TrxG) activities.
Like other herpesviruses, incoming cytomegalovirus genomes
rapidly associate with cellular histone proteins upon entering the
nucleus and numerous studies have confirmed the role chromatin
structure plays in both the lytic and latent phases of cytomega-
lovirus infection [14,15,16,17,18,19,20]. Nucleosomes associate
with the HCMV genome within 30 minutes after infection and are
subject to various PTMs, generating an irregular chromatin
structure on the genome [21]. Studies of both HCMV and
MCMV have documented how changes in histone PTMs at IE, E
and L promoters correlate with changes in gene expression during
acute replication and latency [22,23,24,25,26,27]. Some studies of
HCMV and MCMV replication suggest that the chromatin
structure established on viral genomes upon entering the nucleus
initially serves to repress viral transcription through the formation
of fHC marked by H3K9me2 [23,24,25]. Additionally, multiple
studies support a role for PRCs in regulating a- and c-herpesvirus
gene expression and replication, however, for the b-herpesvirus
sub-family, such an interaction has yet to be characterized. PcG
proteins are known to play central roles in development, stem cell
renewal and differentiation and the cell cycle, cellular processes
that are also intimately linked to the molecular switch between
latent and lytic cytomegalovirus infections [10,11,28,29].
We hypothesized that fHC plays a significant role in the
regulation of MCMV gene expression and analyzed the viral
genome for evidence of histone PTMs characteristic of fHC. We
measured a significant enrichment of the fHC mark H3K27me3 at
the MIE locus of MCMV very early after infection. As the IE
phase proceeds, enrichment of this mark decreases, with
concomitant appearance of H3K4me3, a modification strongly
associated with transcriptionally active chromatin [30,31]. Since
trimethylation of H3K27 is catalyzed by PRC2, and the presence
of H3K27me3 decreases in the IE-to-E transition, we hypothe-
sized that virus infection may actively antagonize PRC2 function
to promote viral gene expression. In response to MCMV infection,
we detected alterations in the nuclear staining of PRC2 proteins,
dependent on the expression of IE proteins and genome
replication. Additionally, we observed that infection resulted in
an increase in chromatin-associated PRC2 and enrichment of
PRC2 proteins in viral replication centers. Taken together, our
results suggest that PRCs participate in the pre-IE repression of
MCMV lytic expression, and that a viral determinant targets
PRC2 to facilitate robust viral transcription and replication.
Results
H3K27me3 is enriched at the MCMV MIE locus at pre-
immediate-early times of infection
Trimethylation of histone H3 on lysine-27 (H3K27me3) is
consistently associated with reversibly silenced domains of
chromatin known as facultative heterochromatin (fHC) [8].
Recent studies have examined the association of repressive PTMs
such as H3K9me2 as well as accessory proteins such as HP1b with
cytomegalovirus promoters, yet none have examined the compo-
sition of viral chromatin with respect to PRC2-catalyzed
H3K27me3-enrichment [23,24,25]. To determine if viral genomes
become associated with H3K27me3, we performed ChIP analysis
of chromatin prepared from mouse fibroblasts infected with
MCMV. To demonstrate that our immunoprecipitations were
specific and efficient, we first validated our ChIP samples by
assessing the enrichment of H3K27me3 at two cellular promoters
compared to the b-actin promoter, which is not expected to
change in histone marks throughout infection. The cellular gene
HoxC11 serves a positive control for H3K27me3-enrichment and
is known to be silenced in a PRC-dependent manner in fibroblasts.
The cellular gene Dlx1 serves as a negative control as it is
transcriptionally active and is not targeted for PRC-mediated
silencing [32]. We observed a 7.4-fold enrichment of H3K27me3
at the promoter of HoxC11 over the negative control, Dlx1 (P
value,0.001; ANOVA) (Fig. 1A).
Fold-enrichment of the H3K27me3 mark at selected loci within
the Major Immediate-Early (MIE) locus and cellular genes was
measured by Taqman quantitative PCR (Q-PCR) analysis relative
to b-actin. ChIP assays were performed on chromatin prepared
from mouse fibroblasts infected with MCMV at a multiplicity of
1.0 and harvested at 1.5, 3, 6 and 12 hours post-infection (hpi).
Using Q-PCR, we probed three loci within the MCMV MIE
region for the presence of H3K27me3: (1) the transcriptional start
site (TSS), (2) the Enhancer 2 element and (3) Exon 1 (Fig. 2A) and
examined the enrichment for significance relative to the negative
control, Dlx1. At 1.5 hpi, we observed significant enrichment of
H3K27me3 at the TSS (6.2-fold), Enhancer 2 (4.9-fold) and Exon
1 (5.0-fold) that was well above the 2.7-fold enrichment observed
at the negative control Dlx1 (Fig. 2B). The significant enrichment
of H3K27me3 is rapidly lost from the TSS, Enhancer 2 and IE1-3
exon1 at 3 hpi, even though enrichment at the negative control
gene, Dlx1 remains constant from 1.5–12 hpi. Over the course of
infection, we also noticed a significant increase in H2K27me3 at
the HoxC11 promoter by 6 hpi, suggesting infection may impact
cellular targets of PRC2 (Fig. S1A). We also performed ChIPs to
PRC2 Activity in MCMV Replication
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levels at the TSS, Enhancer 2 and IE1-3 exon1 remained constant
at the 1.5 and 3 hour time points, suggesting that the loss of
H3K27me3 at these loci is not a consequence of the loss of bulk
histone H3 (Fig. S1B) . It is also possible that the loss of
H3K27me3 on the viral genome was due to amplification of viral
copy number, effectively diluting the number of genomes bound
by H3K27me3. However, by Q-PCR analysis, we detected no
appreciable increase in viral genome copy number until after
12 hpi (Fig. 3). In summary, our data indicate that H3K27me3 is
significantly enriched at the MCMV MIE locus at pre-immediate
early times of infection, suggesting the cellular complex PRC2
targets MCMV genomes for heterochromatin formation. Howev-
er, this repressive chromatin structure is overcome, as indicated by
the rapid loss of H3K27me3 from the MIE locus as the viral
replication cycle proceeds.
H3K4me3 is enriched at the MCMV MIE locus at
immediate-early times of infection
Histone H3 trimethylation on lysine-4 (H3K4me3) is strongly
associated with transcriptional activation [13]. To determine if
MCMV genomes become associated with H3K4me3 during the
IE phase of infection, we again performed ChIP analysis of
chromatin prepared from mouse fibroblasts infected with wild-
type MCMV. To demonstrate that our immunoprecipitations
were specific, we again validated our ChIP samples by assessing
the enrichment of H3K4me3 at HoxC11, Dlx1 and b-actin. As a
transcriptionally active gene, Dlx1 is the positive control, as it is
known to be enriched in H3K4me3, whereas, the transcriptionally
silent HoxC11 gene is devoid of this mark [32]. We observed a
34.7-fold enrichment of H3K4me3 at the promoter of Dlx1 over
the negative control, HoxC11 (P value,0.001; ANOVA) (Fig. 1B).
Fold-enrichment of the H3K4me3 mark at selected loci within
the MIE locus relative to b-actin was measured by Taqman Q-
PCR analysis. ChIP assays were performed on chromatin
prepared from mouse fibroblasts infected with MCMV at 1.5 to
12 hpi with antibody specific for H3K4me3. Relative occupancy
of H3K4me3 at the MIE is detectable but less than our reference
gene b-actin. Hence, the fold-enrichment of H3K4me3 at the
MIE locus has a value,1, but is nevertheless meaningful. At 3, 6
and 12 hpi, we observed significant enrichment (0.34, 0.48, 0.34-
fold enrichment, respectively) of H3K4me3 at Exon 1, relative to
b-actin, that was well above the 0.1-fold enrichment observed at
the negative control HoxC11 (Fig. 4). We detected no significant
enrichment of H3K4me3 at the TSS or Enhancer 2 loci at any of
the time points analyzed. In summary, our data indicate that
H3K4me3 is significantly enriched at a region within the MIE
locus, and remains so, throughout the IE period.
MCMV infection alters the nuclear staining of PRC2
members
The rapid decrease in H3K27me3 at the MIE locus from 1.5 to
3 hpi suggested that MCMV infection may specifically antagonize
the deposition of this mark on viral chromatin. Therefore, we
investigated the consequences of MCMV infection on the sub-
cellular localization of selected PcG proteins as well as PcG protein
expression levels. We first performed immunofluorescence assays
to monitor the sub-cellular localization and distribution of PRC2
proteins in response to MCMV infection. Mouse fibroblasts were
infected with MCMV at an MOI of 1.0. We used recombinant
MCMV that expresses the fluorescent mCherry protein under the
control of the SV40 promoter to permit easy identification of
MCMV-infected cells. At 12 hpi, cells were fixed and stained with
antibodies specific for the PRC2 proteins EZH2 and SUZ12. As
shown in Figure 5, we observed a marked increase in both Suz12
and Ezh2 staining in MCMV infected cells compared to
uninfected cells.
To determine whether the observed, infection-dependent,
increase in PcG immunofluorescence could be explained by an
overall increase in protein expression, we next performed western
blot analysis for the PRC2 proteins EZH2 and SUZ12 as well as
the PRC1 proteins BMI1 and RING1B (Fig. 6). Mouse fibroblasts
were infected with MCMV and harvested from 1.5 hpi to 24 hpi.
Whole cell lysates were prepared and PcG protein levels were
assessed. Compared to mock-infected cells, EZH2, SUZ12, BMI1
and RING1B proteins levels were largely unchanged throughout
the course of the experiment. These results suggest that MCMV
infection has little global effect on the PcG protein expression
levels.
MCMV stimulates PRC2 association with chromatin
during the early phase of lytic infection
We hypothesized that the increase in PRC2-staining in MCMV
infected cells observed in our immunofluorescence assays reflects
an increased association of PRC2 with chromatin during infection.
To test this hypothesis, we performed chromatin fractionation
experiments designed to assay changes in the amount of salt-
Figure 1. Validation of ChIPs for (A) H3K27me3 and (B)
H3K4me3. Chromatin from uninfected mouse fibroblasts was immu-
noprecipitated using anti-H3K27me3 antibody. The specificity of the
ChIPs was assessed by measuring the %Input by Q-PCR at HoxC11, Dlx1
and b-Actin. Each graph displays the mean value and S.E.M. for each
queried locus, with data from four independent ChIPs. *** P value,
0.001.
doi:10.1371/journal.pone.0029410.g001
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and MCMV-infected mouse fibroblasts (MOI 5) from 1.5 hpi to
12 hpi. We also monitored HP1 and HDAC1 levels as reliable
indicators of fractionation efficiency and protein loading, respec-
tively. As shown in Figure 7, between 6 and 12 hpi we observed a
substantial increase in both EZH2 and SUZ12 association with
chromatin, compared to mock-infected cells. This data suggests
that the increase in SUZ12 and EZH2 staining-intensity in the
IFA in response to MCMV infection is likely due to the increased
nucleation of PRC2 complexes, from the nucleoplasm, onto
chromatin.
To determine whether viral gene expression was necessary for
PRC2 enrichment on chromatin, we performed chromatin
fractionations on mock or MCMV-infected cells in the presence
of cycloheximide (Fig. 7). Treatment with cycloheximide prevent-
ed the accumulation of both EZH2 and SUZ12 in the chromatin
fraction over the course of the experiment. This data suggests that
viral gene expression is required for the increase in PRC2
association with chromatin we observe during infection. To
determine if viral DNA replication was necessary for PRC2
enrichment on chromatin, we next performed chromatin frac-
tionations on mock- or MCMV-infected cells treated with
phosphonoacetic acid (PAA). Inhibition of viral DNA replication
by PAA, led to a minimal accumulation of EZH2 and Suz12 in the
chromatin fraction (Fig. 7). This data indicates that viral DNA
replication is also a required step in the increased association of
PRC2 with chromatin we observed during MCMV infection.
H3K27me3 levels increase during MCMV infection
Since MCMV infection enhanced PRC2 association with
chromatin, we hypothesized that H3K27me3 levels would also
increase during infection. To test this hypothesis, we performed
Figure 2. Measurement of H3K27me3 enrichment at the MIE locus of MCMV. (A) Graphical illustration of the MIE locus of MCMV. Solid black
boxes represent regions probed for H3K27me3 & H3K4me3 enrichment. Regions denoted in figure: (1) Represents the Enhancer 2 region, (2) the
transcriptional start site (TSS) of the IE1-3 transcriptional unit and (3) represents Exon 1 within the ORF of the IE1-3 locus. +1 transcriptional start sites
are indicated with black arrows. Enhancer regions are marked in hatched boxes. IE1-3 exons are depicted as gray arrows. (B) H3K27me3 is enriched at
the MIE locus at pre-IE times during MCMV infection. ChIPs using anti-H3K27me3 antibody were analyzed by Q-PCR using primer/probe sets specific
for the indicated loci at 1.5, 3, 6 and 12 hpi as indicated. Each graph displays the mean value and S.E.M. for each queried locus, with data from three
independent ChIPs. The results are presented as the IgG subtracted %Input of the queried locus normalized to the IgG subtracted b-Actin %Input.
Samples with values that vary significantly from the negative control, Dlx1,are indicated by asterisks (* P value,0.05, ** P value,0.01; ANOVA).
doi:10.1371/journal.pone.0029410.g002
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prepared from mock- and MCMV-infected cells (MOI 5).
Compared to mock-infected cells, we detected an increase in the
amount of H3K27me3 in MCMV infected cells at 6 hpi that
continued to increase between 12 and 24 hpi (Fig. 8).
PRC2 localizes to MCMV replication compartments
during lytic infection
Since we found that PRC2 chromatin-association required
viral DNA replication, we asked if PRC2 could be found in viral
replication centers as infection progressed. We performed co-
immunofluorescence assays on MCMV-infected fibroblasts, to
detect the DNA polymerase accessory protein M44, a marker
for replication compartments, in combination with EZH2,
SUZ12 or H3K27me3. At 18 hpi we were able to detect
enrichment of EZH2 and SUZ12 within MCMV replication
compartments, as defined by M44 staining (Fig. 9A and B). We
observed this pattern as early as 12 hpi, and as late as 24 hpi
(Figs. S2 and S3). Surprisingly, although total nuclear
H3K27me3 protein increased as measured by western blot
(Fig. 8) and nuclear H3K27me3 immunofluorescence appeared
to increase in infected cells, MCMV replication compartments
were relatively deficient for this specific histone PTM (Fig. 9D).
The staining patterns for all three antibodies used separately,
were identical to that observed when used in combination,
suggesting our co-immunofluorescence assays represent a true
enrichment of both EZH2 and SUZ12 within viral replication
compartments. In summary, our results demonstrate recruit-
ment of PRC2 to the MCMV replication compartment as early
as 12 hpi, with enrichment increasing as the viral replication
cycle proceeds. However, H3K27me3 was dramatically under-
represented within the replication compartment, suggesting
PRC2 enzymatic activity on newly replicated viral genomes may
be inhibited.
Figure 3. Viral DNA replication kinetics in mouse fibroblasts.
MCMV DNA content on total DNA collected from MCMV infected cells
analyzed by Q-PCR at 1.5, 3, 12, 18 and 24 hpi as indicated. Each graph
displays the mean value and S.E.M. for, with data from three
independent assays. The results are presented as the relative IE1-3
DNA amount normalized to a cellular reference, Dlx1.
doi:10.1371/journal.pone.0029410.g003
Figure 4. Measurement of H3K4me3 enrichment at the MIE locus of MCMV. ChIPs using anti-H3K4me3 antibody were analyzed by Q-PCR
using primer/probe sets specific for the indicated loci at 1.5, 3, 6 and 12 hpi as indicated. Each graph displays the mean value and S.E.M. for each
queried locus, with data from three independent ChIPs. The results are presented as the IgG subtracted %Input of the queried locus normalized to
the IgG subtracted b-Actin %Input. Samples with values that vary significantly from the negative control, HoxC11, are indicated by asterisks (* P value
,0.05; ANOVA).
doi:10.1371/journal.pone.0029410.g004
PRC2 Activity in MCMV Replication
PLoS ONE | www.plosone.org 5 January 2012 | Volume 7 | Issue 1 | e29410Discussion
The assembly of chromatin on viral DNA plays a significant role
in the execution of the lytic or latent replication program of
herpesviruses. During lytic replication, viral genomes initially
associate with nucleosomes with an irregular distribution over the
genome and at levels well below that of cellular genes. As
replication proceeds, newly synthesized viral genomes become
increasingly associated with nucleosomes. Since herpesvirus
genomes acquire modifications typical of transcriptionally active
euchromatin as infection proceeds, it is generally thought that
chromatin structure can play a significant regulatory role in lytic
gene expression. Several studies have implicated the formation of
heterochromatin on cytomegalovirus genomes as an important
step in both lytic and latent infections, using in vitro and in vivo
model systems [23,25,33,34]. However, the molecular mecha-
nisms governing the establishment of heterochromatin and its
regulatory role during infection remain poorly understood.
Figure 5. Immunofluorescence assay for PRC2 proteins during
MCMV infection. At 12 hpi, mock-infected or MCMV:mCherry-
infected fibroblasts were fixed and probed with antibodies against
the PRC2 components, EZH2 or SUZ12. Large arrowheads indicate
MCMV infected cells that also exhibit increased immunofluorescence
signal for EZH2 or SUZ12, while small arrows indicate uninfected
neighboring cells. All images are at 406magnification.
doi:10.1371/journal.pone.0029410.g005
Figure 6. Western blot analysis of PcG protein expression
during MCMV infection. Whole cell lysates were prepared from
mock-infected or MCMV-infected fibroblasts at the indicated times.
Blots were probed with antibodies to the indicated PcG proteins as well
as antibodies against HP-1 and actin as loading controls.
doi:10.1371/journal.pone.0029410.g006
Figure 7. Western blot analysis of PRC2 association with
chromatin during MCMV infection. (A) Validation of chromatin
fractionations. Mouse fibroblasts were fractionated as described in the
Materials and Methods. 25 mg of protein from the soluble (S) and
chromatin (C) fractions were probed for the chromatin-associated
proteins SUZ12, HDAC1 and HP1. The blot was then stripped and re-
probed for the ER-associated protein GRP78. (B) Chromatin fractions
prepared from vehicle-treated (DMSO), cycloheximide (100 mg/ml) or
phosphonoacetic acid (200 mg/ml) treated, mock-infected (M) or
MCMV-infected fibroblasts at the indicated times. Blots were probed
with antibodies against the PRC2 components EZH2 and SUZ12, or
HDAC1 and HP1 for a loading control and fractionation quality control,
respectively.
doi:10.1371/journal.pone.0029410.g007
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of H3K27me3, the central marker of facultative chromatin, with
the MIE locus of the MCMV genome. We observed that
H3K27me3 is rapidly deposited on the viral genome after it
enters the nucleus, perhaps as a cellular response to the
introduction of foreign DNA or perhaps due to intrinsic
sequence-specific signals within the MIE locus that promote the
formation of a heterochromatin-like structure. However, the
enrichment of H3K27me3 is short-lived, as the immediate-early
phase of replication proceeds H3K27me3-enrichment declines,
and we observed a concomitant increase in H3K4me3-enrichment
at Exon 1 within the MIE locus. H3K4me3 is catalyzed by the
mammalian Trithorax complex and may promote transcriptional
activation by recruiting ATP-dependent chromatin remodelers
and stimulating transcriptional elongation [13]. Our observations
suggest that the dynamics of H3K27me3- and H3K4me3-
enrichment at the MIEP of MCMV are much like that of PcG-
repressed cellular genes that become activated in response to
various stimuli. Although we have yet to investigate the
mechanism of PcG and TrxG recruitment to the MIE locus, it
may likely involve transcription factors that bind to the promoter/
enhancer region. Analysis of the MCMV MIEP by another group
revealed numerous potential binding sites for the transcription
factor YY1, a PRC-interacting protein that possesses both
repressing and activating functions [24]. Robust recruitment of
this protein to the MIEP was observed during the acute and latent
phases of infection and could promote PRC interactions with the
MIEP. Alternatively, enrichment of fHC or EC at the MIEP may
be dependent on transcription factors functioning differentially in
a cell-type specific manner.
In an effort to elucidate the consequences of MCMV infection
on PRC2 function and assembly, we discovered that MCMV
infection results in an increased association of EZH2 and SUZ12
with chromatin. Although it is possible that the increased detection
of both EZH2 and SUZ12 in infected cells represents increases in
epitope availability, perhaps due to changes in PRC2 complex
composition or stability, we propose the observed fluorescence
increase represents the nucleation of PRC2 onto chromatin, as
supported by our chromatin fractionation data. The mechanism
that recruits PRC2 into viral replication centers is currently
unknown; viral perturbation of the cell-cycle or a novel viral
determinant could promote the enrichment of PRC2 proteins in
viral replication centers. Interestingly, both cycloheximide and
PAA treatment of MCMV-infected fibroblasts prevented the
observed increase in association of both SUZ12 and EZH2 with
chromatin seen in untreated, MCMV-infected cells. This com-
parative analysis suggests the association of PRC2 with chromatin
is dependent on the formation and maturation of the viral
replication compartment, including DNA replication. Strengthen-
ing the physical link between viral DNA replication and PRC2, we
observed a distinct enrichment for both EZH2 and SUZ12 within
the replication compartment. The association of PRC2 with
chromatin during viral DNA replication suggests PRC2 may be
recruited to viral replication centers. Indeed, in human fibroblasts,
PRC2 co-localizes with PCNA at DNA replication forks during S-
phase [35].
Our observation of PRC2 enrichment within the replication
compartment suggested that H3K27me3 could be associated with
newly replicated viral genomes. Within the cytomegalovirus
replication compartment, newly replicated viral DNA associates
with core histones generating nucleosomal frequencies, at some
loci, that approach those observed for host chromatin [21]. Other
studies have shown that histone PTMs provide regulatory
functions within the replication compartment, as histone PTMs
associated with transcriptional activation are found on late
promoters, at late times post infection [22]. Surprisingly, though,
our results indicate PRC2 activity within the viral replication
compartment may be blocked, as the H3K27me3 enrichment
contained within these structures was, in fact, minimal based on
our IFAs. Formally, we may lose our ability to detect H3K27me3
within viral replication centers; however, we can detect H3K4me3
within the replication compartment (data not shown), suggesting at
least a portion of the H3 N-terminal tail is immunologically
reactive. Productive CMV infection hijacks several cellular
processes, namely cell cycle regulation and major signaling
pathways that impact PRC2 stability, substrate affinity and
enzymatic activity [36,37,38,39]. Consequently, PRC2 targeted
to viral replication compartments, may be functionally impaired.
Alternatively, recruited PRC2 may provide a function indepen-
dent of histone H3 post-translational modification. A third
explanation could be that CMV replication forks may contain or
recruit cellular antagonists of PRC2, thereby uncoupling PRC2
activity from newly synthesized genomes [40]. Recruitment of the
H3K27-specific demethylases KDM6A and KDM6B to viral
DNA replication machinery could, in fact, counteract faithful
transmission of PRC2 catalyzed heterochromatic PTMs to
daughter DNA strands. Thus, the activity of these demethylases
early at the onset of viral DNA replication would allow for rapid
expansion of viral chromatin lacking PRC2-catalyzed heterochro-
matin. Further, strong evidence exists for an interaction between
KDM6A/B and the Trithorax complex, potentially creating a
euchromatic chromatin environment refractory for H3K27me3
deposition [41,42].
Paradoxically, we observed that total H3K27me3 levels increase
over time in infected fibroblasts, and our ChIP data revealed a
significant increase in H3K27me3 enrichment at the HoxC11
promoter over the course of infection. Collectively, these
observations provide evidence for lytic infection affecting host
chromatin dynamics. We would predict, in infected cells,
H3K27me3 enrichment at cellular chromatin would be enhanced,
at numerous PRC2 responsive regions. We postulate that host
chromatin increases in H3K27me3 levels may occur as a
consequence of virally induced nuclear reorganization, including
the exclusion of host chromatin to the nuclear margins in infected
cells, allowing promiscuous transfer of epigenetic information
between adjacent strands of host DNA that would otherwise be
well separated within the nucleus. Alternatively, functional
antagonists of PRC2 activity, such as KDM6A and KDM6B,
may be actively recruited to viral replication compartments,
leaving PRC2 activity at cellular chromatin unchecked.
It is likely that cytomegalovirus has evolved mechanisms to
interfere with the inhibitory chromatin structure and promote an
active conformation on viral promoters for lytic replication to
proceed efficiently. To prevent sustained inhibition by the cellular
protein complexes that establish and maintain heterochromatin,
we postulate there must be viral determinants that promote the
Figure 8. Western blot analysis of cellular H3K27me3 levels
during MCMV infection. Whole cell lysates were prepared from
mock-infected or MCMV-infected fibroblasts at the indicated times.
Blots were probed with antibodies against H3K27me3 or total H3.
doi:10.1371/journal.pone.0029410.g008
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methylation of H3K27 and recruit cellular proteins that modify
chromatin structure to permit robust transcriptional activation. It
is well established that tegument and IE proteins antagonize the
activity of histone deacetylases and interact with protein complexes
that modify and remodel nucleosomes to facilitate transcriptional
initiation and elongation by RNA polymerase II [43,44,45].
Future studies will aim to identify viral determinants modulating,
directly or indirectly, PcG mediated epigenetic repression.
Further, it will be important to identify the scope with which
PRCs influence cytomegalovirus gene expression during lytic and
latent types of infection. Polycomb mediated transcriptional
repression is plastic in nature, and represents a robust cellular
programming system capable of executing gene expression
patterns in an exact manner. Similarly, the transcriptional
programs for both lytic and latent cytomegalovirus infections are
Figure 9. Co-immunofluorescence assay for PRC2 enrichment within MCMV replication compartments. At 18 hpi, mock-infected or
MCMV-infected fibroblasts were fixed and incubated with antibodies against M44 and (A) EZH2, (B) SUZ12 or (C) H3K27me3. (D) Purified rabbit IgG
served as an isotype control. The first column of panels displays DAPI staining for nuclei. The second column of panels displays M44 staining, marking
MCMV replication compartments. The third column of panels displays staining EZH2, SUZ12, H3K27me3 or isotype IgG. The fourth column of panels
displays a merged image of the first three channels. The fifth column of panels displays a high-magnification image of the merged image from the
fourth column. All images are 406, unless otherwise indicated.
doi:10.1371/journal.pone.0029410.g009
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interaction between Polycomb Repressive Complexes and CMV
may confer advantageous properties for the virus, by regulating
cell- and context-dependent transcriptional programs.
Materials and Methods
Cells and virus
10.1 mouse embryo fibroblasts [46] were propagated in DMEM
with 10% fetal calf serum. Wild-type MCMV was derived from
pSM3fr, a BAC clone of the Smith strain and titered by plaque
assay on 10.1 cells [47,48].
Two wild-type recombinant derivatives of MCMV were used in
experiments. MCMV:mCherry expresses the fluorescent mCherry
protein under the control of the SV40 promoter. The SV40-
mCherry cassette is inserted at the m156 ORF and this
recombinant virus grows with wild-type kinetics in fibroblasts.
MCMV:m106-GFP is a recombinant MCMV that expresses the
m106 ORF as a green fluorescent protein fusion. This recombi-
nant virus expresses m106-GFP at late times of infection and
grows with wild-type kinetics in fibroblasts (manuscript in
preparation). Virus was inactivated by UV treatment using a
Stratalinker 1800 (Stratagene) and exposing the virus to 2.4610
6
mJoules of UV radiation. Virus inactivation was assessed by plaque
assay.
Primers
Quantitative PCR (Q-PCR) reagents and Taqman probes were
purchased from Applied Biosystems. Taqman assays were
designed using MacVector or Primer-BLAST (http://www.ncbi.
nlm.nih.gov/tools/primer-blast/). A full listing of primer/probe
sequences used in our studies is found in Table 1.
Antibodies
Antibody sources and usage for different experiments are as
follows: EZH2 (WB 1:1000, IF 1:200), SUZ12 (WB1:1000, IF
1:800) and H3K4me3 (ChIP 5 ug) were purchased from Cell
Signaling. BMI1 (WB 1:2500), RING1B (WB 1:2500), pan-H3
(WB 1:5000) and H3K27me3 (ChIP 5 ug, IF 1:200, WB 1:5000)
were purchased from Millipore. HDAC1 (WB 1:1000), HP1 (WB
1:1000), and GRP78 (WB 1:1000) were purchased from Santa
Cruz. b-Actin (WB 1:15,000), Goat anti-Mouse/Alexa 488 (IF
1:1000) and Goat anti-Mouse/Alexa 594 (IF 1:1000) were
purchased from Invitrogen. Goat anti-Rabbit/FITC (IF 1:200),
Goat anti-Rabbit/HRP (WB 1:10,000) and Goat anti-Mouse/
HRP (WB 1:10,000) were purchased from Jackson Labs. The M44
(IF 1:500) antibody was a kind gift from Dr. Carol Wu at the
University of Connecticut Health Sciences Center. Normal Rabbit
IgG (ChIP 5 ug) was purchased from Abcam.
SDS-PAGE
Mock-infected and MCMV-infected cells were scraped and
collected in PBS; following two PBS washes, cells were centrifuged
and either flash frozen at 280uC for later use or processed for
SDS-PAGE. Cells were lysed in RIPA buffer (150 mM NaCl, 1%
v/v Nonidet P-40, 0.5% w/v deoxycholate, 0.1% w/v SDS,
5 mM EDTA, 50 mM Tris; pH 8.0) containing protease inhibitor
cocktail (ThermoScientific). The cell lysate was briefly sonicated to
facilitate nuclear protein release and insoluble debris was
centrifuged. The soluble lysate was assayed for protein content
using Bradford reagent (Bio-Rad). 50 mg of protein from each
sample was separated by SDS-PAGE on a 12% gel.
Western Blotting
Following transfer of SDS-PAGE-separated proteins to nitro-
cellulose, blots were blocked in 5% dry milk in PBST or TBST,
depending on manufacturer recommendations for each antibody,
for 1–2 hours at room temperature. Blots were incubated with
primary antibody diluted in blocking buffer overnight at 4uC.
After washing, blots were incubated with secondary antibody
diluted 0.1% dry milk in PBST or TBST for 1 hour at room
temperature. Chemiluminescent detection was performed using
SuperSignal West Pico Chemiluminescent Substrate (Thermo-
Scientific).
Chromatin Fractionation
Separation of salt sensitive chromatin binding proteins from
soluble proteins was performed as described in [49]. Briefly,
fibroblasts were infected with MCMV at an MOI of 1.0 or mock-
infected. 5610
6 cells were rinsed and resuspended in 1 ml cold
PBS. Following centrifugation, the cell pellet was resuspended in
NB buffer (15 mM Tris pH7.4, 0.3% NP40, 5 mM MgCl2,
60 mM KCl, 15 mM NaCl, 1 mM DTT, 250 mM Sucrose) and
incubated on ice for 5 minutes. Following centrifugation at
1,3006g the supernatant (soluble fraction) was collected. The
pellet was rinsed once in NB and extracted in TTEM-250 (20 mM
Tris pH7.4, 1% Triton X-100, 2 mM EDTA, 10 mM MgCl2,
250 mM NaCl, 10% Glycerol) and incubated on ice for
30 minutes. Following centrifugation at 10,0006g the supernatant
(chromatin fraction) was collected and analyzed by western blot for
EZH2, SUZ12, HDAC1 and HP1 proteins.
Immunofluorescence
Mouse fibroblasts were plated on sterile glass cover slips for
immunofluorescence assays. At the time of the assay, mock-
infected and MCMV-infected cells were washed with PBS and
then fixed with 4% paraformaldehyde in ddH20, pH 7.4 for
15 minutes, or fixed in methanol at 220uC for 10 min. Post
fixation, free aldehyde groups were quenched using ice cold 0.1 M
glycine in PBS. Cells were permeablized on ice by incubation in
Table 1. Q-PCR Primers and Probes.
Dlx1 Fwd: ACACCCAGACCCCGCGAGAA
Rev: ACACAGCCTTGCCCGACAC
Probe: TGACCATGACCACCATGCCAGA
HoxC11 Fwd: GGAACCGTCCGGGAAGTGGC
Rev: TGCATAAGCTCGTCGGCCGC
Probe: ACCATCGGAACAGCTACTCGTCT
b-Actin [23] Fwd: CGTTCCGAAAGTTGCCTTTTA
Rev: GCCGCCGGGTTTTATAGG
Probe: CTCGAGTGGCCGCTG
MIE TSS [23] Fwd: GGTGGTCAGACCGAAGACT
Rev: GCTGAGCTGCGTTCTACGT
Probe: CTGGTCGCGCCTCTTA
MIE Enhancer 2 Fwd: TTTGACTCAGTGTGCTTGCC
Rev: TGACTCAATGGCCTTTACCC
Probe: TTGGCTTACCTCCCATTGAC
MIE Exon 1 Fwd: TTCGCAGTACGAGCAACAAC
Rev: TGCTCAGATCGTCTCCTGTG
Probe: CAGGAACTGACGGAGTCCTC
doi:10.1371/journal.pone.0029410.t001
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10 minutes. Cells were then washed 3 times for 5 minutes each in
cold PBST (0.2% Tween 20 in PBS) followed by incubation with
blocking buffer (5% BSA, 0.2% Tween20 in PBS) for 1–2 hours at
room temperature. Primary antibody was diluted in blocking
buffer and incubated with the cells in a humid chamber for 1–
2 hours at 37uC. Cover slips were then washed 3 times 5 minutes
each in cold PBST. Secondary antibody incubations and washes
were performed as described for primary antibody. Following the
last PBST wash, cover slips were rinsed 2 times in ice cold PBS
and then mounted onto glass microscope slides using SlowFade
Reagent (Invitrogen) containing DAPI.
Image Acquisition
All imaging was performed in the University of Colorado
Denver Advanced Microscopy Core Facility. Confocal image
acquisition was done with an Olympus IX81 inverted motorized
microscope with spinning disk attachment. UAPO 406 oil N.A.
1.35, and U PLAN APO 1006oil N.A. 1.35 objectives were used.
Excitation source was from a 100 watt Hg lamp. Image collection
was completed with a Hamamatsu ORCA IIER monochromatic
CCD camera 134461024 full chip, 6.4566.45 mm pixel. Filter sets
used were, for DAPI: Excitation 360-70 & Emission 420-60, for
FITC: Excitation 450-80 & Emission 535 and for TRITC
Excitation 535 & Emission 635. Intelligent Imaging Slidebook
version 4.067 was used as acquisition software. Immunofluores-
cence data was collected from many fields of view across multiple
independent experiments. Collected images were processed using
Image J software (NIH).
Chromatin Immunoprecipitation (ChIP)
1610
7 mock-infected or MCMV-infected fibroblasts were
fixed with 1% formaldehyde/PBS for 10 minutes at room
temperature. Fixation was terminated by adding glycine/PBS to
a final concentration of 125 mM and incubating for 5 minutes
at room temperature with rocking. Cells were scraped in
DMEM containing 10% Newborn Calf Serum and protease
inhibitor cocktail (Roche) and collected by centrifugation at
8006 g for 5 minutes. The cell pellet was resuspended and
washed twice with ice cold PBS containing protease inhibitor
cocktail. Cells were lysed in 1 ml IP Lysis Buffer (150 mM NaCl,
0.5% Nonidet P-40, 1% Triton X-100, 5 mM EDTA, 50 mM
Tris pH 7.5) for 10 minutes and the nuclei collected by
centrifugation for 5 minutes at 12,0006 g.N u c l e iw e r e
resuspended in Nuclear Lysis Buffer (1% SDS, 10 mM EDTA,
50 mM Tris pH 8.1) and mechanically disrupted with several
passages through a 22G1 syringe needle. Chromatin was
sonicated to fragments 200–1000 bp in length using a Fisher
100 Sonic Dismembrator at a power setting of 8. Sonication was
performed as 8 pulses of 5 seconds each with 2 minutes of rest
on ice between each pulse. Insoluble aggregates were cleared by
centrifugation at 14,0006 g for 10 min. For each immunopre-
cipitation (IP), ,2610
6 cell equivalents of cleared chromatin
was diluted 1:10 in ChIP dilution buffer (167 mM NaCl, 0.01%
SDS, 1.1% Triton X-100, 16.7 mM Tris pH 8.1, 1 mM EDTA)
containing protease inhibitor cocktail supplemented with 1 mM
PMSF. Antibody (5 mg) and Protein A-coupled magnetic beads
(20 mL) (Millipore), were added to each IP and incubated at 4uC
overnight with rotation. Magnetic beads retaining the immune
complexes were then washed. After the final wash, beads were
resuspended in 100 ml 10% Chelex 100 resin (BioRad) and
40 mg Proteinase K. After brief vortexing, samples were
incubated at 57uC for 45 minutes on a Thermomixer (Eppen-
dorf) with shaking. Samples were then incubated at 96uCf o r
20 minutes on a Thermomixer with shaking, then cooled on ice
and collected by centrifugation. The supernatant was collected
and assayed by quantitative PCR. 1% of each of the input
chromatin DNA and the ChIP DNA samples were assayed by
Q-PCR in triplicate using a Roche LightCycler 480. Fold-
enrichments of histone marks at various genomic loci were
calculated as IgG-subtracted %Input of the queried locus
divided by the IgG-subtracted %Input of the reference gene
b-actin. Statistical comparisons were made by one-way ANOVA
followed by Tukey’s multiple comparisons post-test using Graph
Pad Prism 5 software.
Viral DNA Replication Assay
Mouse fibroblasts were infected with WT MCMV:mCherry at a
MOI of 1. At 1.5, 3, 12, 18 and 24 hpi cells were harvested by
scraping, washed 2 times in PBS and then flash frozen until use.
For total DNA collection, samples were processed using a
QIAamp DNA Mini Kit (Qiagen) according to the manufacturer’s
recommendations. Viral DNA was quantified by Q-PCR in
triplicate, using the IE1-3 primer set. Each sample was normalized
to cellular Dlx1 DNA levels.
Supporting Information
Figure S1 ChIP analysis of (A) H3K27me3 enrichment at
the HoxC11 locus and (B) histone H3 at the MIE locus
during MCMV infection. H3K27me3 enrichment was mea-
sured in mouse fibroblasts from 1.5 to 12 hpi. (* P value,0.05,
ANOVA). ChIPs using anti-H3 antibody were analyzed by Q-
PCR using primer/probe sets specific for the indicated loci at 1.5
(black bars) and 3 hpi (gray bars) as indicated. Each graph displays
the mean value and S.E.M. for each queried locus, with data from
two independent ChIPs. The results are presented as the IgG
subtracted %Input of the queried locus normalized to the IgG
subtracted b-Actin %Input.
(TIF)
Figure S2 Co-immunofluorescence assay for PRC2
enrichment within MCMV replication compartments.
At 12 and 24 hpi, mock-infected or MCMV-infected fibroblasts
were fixed and incubated with antibodies against M44 and (A)
EZH2 or (B) SUZ12. The first column of panels displays DAPI
staining for nuclei. The second column of panels displays M44
staining, marking MCMV replication compartments. The third
column of panels displays staining EZH2 or SUZ12. The fourth
column of panels displays a merged image of the first three
channels. The fifth column of panels displays a high-magnification
image of the merged image from the fourth column. All images are
406, unless otherwise indicated.
(TIF)
Figure S3 Co-immunofluorescence assay for PRC2
enrichment within MCMV replication compartments.
At 12 and 24 hpi, mock-infected or MCMV-infected fibroblasts
were fixed and incubated with antibodies against M44 and (A)
H3K27me3 or (B) purified rabbit IgG as an isotype control. The
first column of panels displays DAPI staining for nuclei. The
second column of panels displays M44 staining, marking MCMV
replication compartments. The third column of panels displays
staining H3K27me3 or isotype IgG. The fourth column of panels
displays a merged image of the first three channels. The fifth
column of panels displays a high-magnification image of the
merged image from the fourth column. All images are 406, unless
otherwise indicated.
(TIF)
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